Gene therapy stories
Fuse Vectors secures USD $5.2m for gene therapy tech
Last week
#
healthtech
#
funding
#
capital raising
Danish biotech firm Fuse Vectors has secured USD $5.2 million in pre-seed funding to advance its innovative cell-free gene therapy technology.
Peptide APIs drive growth in targeted therapy market
Thu, 30th Jan 2025
#
growth
#
pharmaceuticals
#
gene therapy
The peptide Active Pharmaceutical Ingredient market is poised for significant growth, driven by demand for targeted therapies and advances in synthesis technology.
Honeywell tech powers Peter Mac's AUD $105m cell and gene therapy manufacturing facility
Fri, 6th Sep 2024
#
it in manufacturing
#
partner programmes
#
risk & compliance
Honeywell supports Peter Mac’s AUD $105M Melbourne facility, Australia’s first to commercialise CAR T-cell therapies, with advanced building tech.